Targeted Capacity Expansion:

Medication-Assisted Treatment – Prescription Drug and Opioid Addiction (MAT-PDOA)

Overview of Project: Baltimore City

The 3-year MAT-PDOA grant was awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) to the Maryland Department of Health and Mental Hygiene (DHMH). DHMH made awards to Baltimore City and Anne Arundel County. This document describes the work to be funded by the MAT-PDOA grant in Baltimore City from 8/1/15 to 7/31/18.

Purpose: The purpose of the MAT-PDOA project is to enhance and expand the substance use treatment system for people with opioid use disorders.

Strategies

a)Buprenorphine induction in 3.7 residential care (Tuerk House)

  • A physician will provide buprenorphine induction to eligible and interested patients while they are in residential treatment for opioid use disorder.
  • Total Health Care peer recovery specialists/care coordinators will:
  • Provide support to 3.7 buprenorphine patients at Tuerk House
  • Assist with patients’ transition from 3.7 care to ongoing buprenorphine treatment at Total Health Care or another provider

b)Enhanced recovery support in medication-assisted treatment (MAT) programs

(Total Health Care, Reflective Treatment Center, Daybreak Rehabilitation Center)

  • Participating MAT programs will hire 2 FTE peer recovery specialists and/or care coordinators to provide enhanced recovery support to patients, including:
  • Implementation of Medication-Assisted Recovery Services Project (MARS) at MAT program (see
  • Care coordination and access to recovery support services available through Maryland RecoveryNet
  • Peer support
  • Only the following people are eligible to access Maryland Recovery Net through the onsite MAT-PDOA care coordinator(s):
  • At Daybreak and Reflective: patients who note at intake that they have experienced an overdose in the past
  • At Total Health Care: patients who have transitioned from 3.7 care to outpatient buprenorphine treatment
  • People who access Maryland Recovery Net through the onsite MAT-PDOA care coordinator will also be asked to complete the GPRA (SAMHSA’s evaluation survey). The MAT-PDOA care coordinator will administer the GPRA.

Objectives and Project Overview

Objectives / Strategy / Partners / Who can receive Maryland RecoveryNet care coordination from onsite MAT-PDOA care coordinator at this site?*
(These are also the people who will do the GPRA surveys.)
1 / Increase number of clients in 3.7 care receiving buprenorphine induction. / Buprenorphine induction in 3.7 care (at Tuerk House) / Tuerk House (induction)
BHSB medical director (training)
Total Health Care (peer support and linkage to ongoing care) / No one
2 / Increase referrals from 3.7 care to medication-assisted treatment (MAT) programs.
3 / Increase length of stay in MAT by 40%. / Enhanced recovery support in MAT programs
(including peer support, MARS groups, care coordination, and access to Maryland RecoveryNet services) / MAT programs:
  • Daybreak Rehabilitation Program (methadone)
  • Reflective Treatment Center (methadone)
  • Total Health Care (buprenorphine)
/ Daybreak & Reflective:
Any new patient who says at intake that he/she has experienced an overdose in the past.
Total Health Care:
Anyone who started buprenorphine in 3.7 care at Tuerk House and then transitioned to Total Health Care for ongoing buprenorphine treatment.
4 / Reduce patients leaving MAT against medical advice by 20%.
5 / Decrease illicit drug use by those in MAT.
6 / Prevent opioid-related deaths. / Both of the above / All of the above / N/A

3/10/161